Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530016) titled 'Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma' on April 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The First Affiliated Hospital of Xinxiang Medical College
Condition:
Melasma
Treatment of Stable Melasma
Tranexamic Acid
Laurocapram
Intervention:
Combination Product: Ligustrazine - tranexamic acid - aloe polysaccharide composite gel
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollme...